Product Summary

  • 96 well assay for use with human urine
  • Assay range of 1.25 - 40μg/L
  • Pi GST is found specifically in distal tubules only
  • Published as an early indicator of Stage 3 Acute Kidney Injury
  • Research use only - Not for use in diagnostic procedures


Human Pi-GST ELISA

Assay Principle

Our Pi GST EIA is a quantitative enzyme immunoassay. The test procedure is based on the sequential addition of sample, antibody-enzyme conjugate and substrate to Microassay wells coated with anti-πGST IgG. The resultant colour intensity is proportional to the amount of πGST. The assay range is 1.25 - 40μg/L.

Performance Characteristics

MEASURING RANGE

The calibration curve range covers 1.25 - 40μg/L, corresponding to 3.13 - 100μg/L in stabilised urine samples diluted 1/2 in Sample Diluent. This range may be extended by increasing sample dilution.

SPECIFICITY
Our Pi GST EIA is highly specific for πGST. No cross-reactivity was observed with µGST at 500μg/L or αGST at 500μg/L.

SENSITIVITY
The limit of detection (LoD) of Argutus Medical Pi GST EIA was estimated from 60 blank sample measurements and 60 replicates of low-level sample measurements as per CLSI Document EP17-A. The limit of detection was found to be 1.3μg/L, which corresponds to a concentration of 3.25μg/L in a stabilised urine sample diluted 1/2.
 

For more information on this product and it's usage see the links to product documentation on this page. Alternatively, feel free to contact us.

 

 

Want to Order?

See Ordering Details

Product Documentation

Inserts Icons

 

© 2012 Argutus Medical Ltd
  • Trinity Technology & Enterprise Campus Pearse St Dublin 2 Ireland
  • Phone: +353 1 670 8576
  • Fax: +353 1 670 8575
  • Email: info@argutusmed.com

Search

Search - Use spaces to separate your keywords